Search Within

Maria Lia Palomba

Formats
  1. Meeting Abstract (289)
  2. Journal Article (131)
  3. Research Letter (10)
  4. Review (8)
  5. Correspondence (4)
  6. Editorial (3)
  7. Book Section (1)
  8. Conference Paper (1)
  9. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (448)
  2. Department of Medicine (448)
  3. Hematologic Malignancies, Division of (448)
  4. Lymphoma (448)
  5. Hematology-Oncology Fellows (228)
  6. Survivorship Research (209)

More Groups

People
  1. Andrew Zelenetz (143)
  2. Ariela Noy (132)
  3. Paul Hamlin (126)
  4. Gilles Salles (114)
  5. Steven Horwitz (112)
  6. Gunjan Shah (111)

More People

Years
  1. 2025 (19)
  2. 2024 (58)
  3. 2023 (69)
  4. 2022 (39)
  5. 2021 (41)
  6. 2020 (43)

More Years

Publications
  1. Blood (187)
  2. Journal of Clinical Oncology (37)
  3. Hematological Oncology (30)
  4. Blood Advances (19)
  5. Blood Cancer Journal (15)
  6. British Journal of Haematology (14)

More Publications

Publishers
  1. American Society of Hematology (207)
  2. Elsevier Inc. (45)
  3. American Society of Clinical Oncology (38)
  4. Nature Publishing Group (33)
  5. Wiley Blackwell (31)
  6. John Wiley & Sons (14)

More Publishers

Results (448)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenström macroglobulinemia
    Journal Article

    Castillo, J. J.; Gustine, J. N.; Meid, K.; Dubeau, T. E.; Xu, L.; Yang, G.; Hunter, Z. R.; Advani, R.; Palomba, L.; Treon, S. P.
    Haematologica (2018)

    Fulltext@MSK | Save
  • Ibrutinib/rituximab versus placebo/rituximab: A randomized, phase 3 trial in Waldenström's macroglobulinemia (iNNOVATE)
    Meeting Abstract

    Palomba, M. L.; Dimopoulos, M. A.; Tedeschi, A.; Trotman, J.; García-Sanz, R.; MacDonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Tam, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save
  • First-generation and second-generation Bruton tyrosine kinase inhibitors in Waldenström macroglobulinemia
    Journal Article

    Argyropoulos, K. V.; Lia, M.
    Hematology/Oncology Clinics of North America (2018)

    Fulltext@MSK | Save
  • Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: A dose-escalation, phase I study
    Journal Article

    Stathis, A.; Flinn, I. W.; Madan, S.; Maddocks, K.; Freedman, A.; Weitman, S.; Zucca, E.; Munteanu, M. C.; Lia Palomba, M.
    Investigational New Drugs (2018)

    Fulltext@MSK | Save
  • Rituximab plus lenalidomide in advanced untreated follicular lymphoma
    Journal Article

    Morschhauser, F.; Fowler, N. H.; Feugier, P.; Bouabdallah, R.; Tilly, H.; Palomba, M. L.; Fruchart, C.; Libby, E. N.; Casasnovas, R.O.; Flinn, I. W.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Serious infections in patients receiving ibrutinib for treatment of lymphoid cancer
    Journal Article

    Varughese, T.; Taur, Y.; Cohen, N.; Palomba, M. L.; Seo, S. K.; Hohl, T. M.; Redelman-Sidi, G.
    Clinical Infectious Diseases (2018)

    Fulltext@MSK | Save
  • Phase 3 trial of Ibrutinib plus rituximab in Waldenström's macroglobulinemia
    Journal Article

    Dimopoulos, M. A.; Tedeschi, A.; Trotman, J.; García-Sanz, R.; Macdonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Tam, C.; Orsucci, L.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
    Journal Article

    Intlekofer, A. M.; Joffe, E.; Batlevi, C. L.; Hilden, P.; He, J.; Seshan, V. E.; Zelenetz, A. D.; Palomba, M. L.; Moskowitz, C. H.; Portlock, C.; more...
    Blood Cancer Journal (2018)

    Fulltext@MSK | Save
  • A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL
    Journal Article

    Sauter, C. S.; Matasar, M. J.; Schoder, H.; Devlin, S. M.; Drullinsky, P.; Gerecitano, J.; Kumar, A.; Noy, A.; Palomba, M. L.; Portlock, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • High durable CR rates and preliminary safety profile for JCAR017 in R/R aggressive B-NHL (TRANSCEND NHL 001 study): A defined composition CD19-directed CAR T cell product with potential for outpatient administration
    Meeting Abstract

    Abramson, J. S.; Siddiqi, T.; Palomba, M. L.; Gordon, L. I.; Lunning, M. A.; Arnason, J. E.; Wang, M.; Forero-Torres, A.; Albertson, T.; Dehner, C.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save